Table 1 presents the Phase 5 distribution of self reported health, minor psychiatric morbidity, physiological measures, and health related behaviours for control participants (continued secure employment) and participants in the three exposure groups: insecure at Phase 4 and secure at Phase 5; secure at Phase 4 and insecure at Phase 5; and insecure at both phases. The effects of these exposures on self reported health, minor psychiatric morbidity, physiological measures, and health related behaviours at Phase 5, relative to outcomes for control participants are presented in table 2. Analyses adjusted for negative affect produced results similar to those presented in table 2 (data not shown).